These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11054344)

  • 21. Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension.
    Morikawa T; Imanishi M; Suzuki H; Okada N; Okumura M; Konishi Y; Yoshioka K; Takai S; Miyazaki M
    Am J Kidney Dis; 2005 Mar; 45(3):e45-50. PubMed ID: 15754263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis.
    Kendrick J; Chonchol M
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):355-62. PubMed ID: 18805381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts in the management of renovascular hypertension and ischemic renal failure.
    Novick AC
    Am J Kidney Dis; 1989 Jun; 13(6 Suppl 1):33-7. PubMed ID: 2525335
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.
    Woolfson RG
    Postgrad Med J; 2001 Feb; 77(904):68-74. PubMed ID: 11161070
    [No Abstract]   [Full Text] [Related]  

  • 25. Atherosclerotic ischemic nephropathy. Epidemiology and clinical considerations.
    Novick AC
    Urol Clin North Am; 1994 May; 21(2):195-200. PubMed ID: 8178387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic nephropathy: more than a simple renal artery narrowing.
    Khatami MR
    Iran J Kidney Dis; 2013 Mar; 7(2):82-100. PubMed ID: 23485531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerotic renovascular disease and progressive renal failure.
    Rimmer JM; Gennari FJ
    Ann Intern Med; 1993 May; 118(9):712-9. PubMed ID: 8460859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerotic ischemic renal disease.
    Greco BA; Breyer JA
    Am J Kidney Dis; 1997 Feb; 29(2):167-87. PubMed ID: 9016887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic nephropathy - pathogenesis and treatment.
    Adamczak M; Wiecek A
    Nefrologia; 2012 Jul; 32(4):432-8. PubMed ID: 22806277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications.
    Covic A; Gusbeth-Tatomir P
    Prog Cardiovasc Dis; 2009; 52(3):204-8. PubMed ID: 19917331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease.
    van de Ven PJ; Beutler JJ; Kaatee R; Beek FJ; Mali WP; Koomans HA
    Kidney Int; 1998 Apr; 53(4):986-93. PubMed ID: 9551408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischaemic nephropathy: can we preserve renal function?
    Vidt DG
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S70-3. PubMed ID: 11986899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of ischemic nephropathy in the atherosclerotic population.
    Hansen KJ
    Am J Kidney Dis; 1994 Oct; 24(4):615-21. PubMed ID: 7942819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitor-induced acute renal failure in a patient with progressive systemic sclerosis: ischemic nephropathy mimicking PSS renal crisis.
    Shinohara M; Washida N; Tanaka A; Ueda S; Kuwahara T; Kojima H
    Intern Med; 2007; 46(18):1605-7. PubMed ID: 17878652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of ischemic nephropathy: dialysis-free survival after surgical repair.
    Hansen KJ; Cherr GS; Craven TE; Motew SJ; Travis JA; Wong JM; Levy PJ; Freedman BI; Ligush J; Dean RH
    J Vasc Surg; 2000 Sep; 32(3):472-81; discussion 481-2. PubMed ID: 10957653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atherosclerotic renovascular hypertension: clinical findings and results of treatment over 15 years].
    Alfonzo JP; Rosario MN; Ugarte C; Banasco J; Fraxedas R; Lahera J
    Nefrologia; 2003; 23(2):150-9. PubMed ID: 12778880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of renal revascularization on the development of renal dysfunction in atherosclerotic ischemic nephropathy.
    Hagemann R; Silva Vdos S; Franco RJ; Barretti P; Martin LC
    J Bras Nefrol; 2014; 36(4):535-41. PubMed ID: 25517284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy].
    Oksa A; Dzúrik R; Demes M
    Vnitr Lek; 2003 Mar; 49(3):217-21. PubMed ID: 12728596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibromuscular dysplasia of the renal arteries].
    Fiquet-Kempf B; Grimbert P; Pannier-Moreau I; Vuagnat A; Jeunemaitre X; Plouin PF
    Nephrologie; 1999; 20(1):13-8. PubMed ID: 10081032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.